| MGQLX | RWIBX | MGQLX / RWIBX | |
| Total Expense Ratio | 1.65 | 1.51 | 109% |
| Annual Report Gross Expense Ratio | 2.45 | 1.51 | 162% |
| Fund Existence | 13 years | 24 years | - |
| Gain YTD | -4.461 | 13.017 | -34% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21.6M | 160B | 0% |
| Annual Yield % from dividends | 0.00 | 0.74 | - |
| Returns for 1 year | -29.38 | 17.83 | -165% |
| Returns for 3 years | -28.69 | 46.73 | -61% |
| Returns for 5 years | -32.61 | 27.84 | -117% |
| Returns for 10 years | 3.88 | 98.11 | 4% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BIPSX | 44.07 | N/A | N/A |
| ProFunds Biotechnology UltraSector Svc | |||
| TSVRX | 22.11 | N/A | N/A |
| PGIM Quant Solutions Small-Cap Val R | |||
| ACAYX | 66.15 | N/A | N/A |
| Alger Capital Appreciation Instl Y | |||
| FIJCX | 89.83 | N/A | N/A |
| Fidelity Advisor Consumer Staples Z | |||
| DFIEX | 22.01 | -0.42 | -1.87% |
| DFA International Core Equity 2 I | |||